Search
NEWS

First-in-human study of the safety, pharmacokinetics, and

By A Mystery Man Writer

First-in-human study of the safety, pharmacokinetics, and

Human disease models in drug development

First-in-human study of the safety, pharmacokinetics, and

Pacylex Pharmaceuticals Reports Safety and Efficacy Results from

First-in-human study of the safety, pharmacokinetics, and

Find a clinical trial

First-in-human study of the safety, pharmacokinetics, and

Biomolecules, Free Full-Text

First-in-human study of the safety, pharmacokinetics, and

Safety and pharmacokinetics (PK) of single rising oral doses of a

First-in-human study of the safety, pharmacokinetics, and

Frontiers Progress of potential drugs targeted in lipid metabolism research

First-in-human study of the safety, pharmacokinetics, and

Phase 1A/1B dose-escalation and -expansion study to evaluate the

First-in-human study of the safety, pharmacokinetics, and

Frontiers Progress of potential drugs targeted in lipid metabolism research

First-in-human study of the safety, pharmacokinetics, and

Frontiers Fatty acid metabolism: A new therapeutic target for cervical cancer

First-in-human study of the safety, pharmacokinetics, and

Gerald FALCHOOK, Director, Drug Development, Sarah Cannon Research Institute, Nashville

First-in-human study of the safety, pharmacokinetics, and

Safety and activity of RRx-001 in patients with advanced cancer: a

First-in-human study of the safety, pharmacokinetics, and

Lipogenesis inhibitors: therapeutic opportunities and challenges

First-in-human study of the safety, pharmacokinetics, and

IJMS, Free Full-Text